C. Lewden, T. May, E. Rosenthal, C. Burty, F. Bonnet et al., Changes in causes of death among adults infected by HIV between, 2000.
URL : https://hal.archives-ouvertes.fr/inserm-00337877

, J. Acquir. Immune Defic. Syndr, vol.48, pp.590-598

L. Dal-maso, J. Polesel, D. Serraino, M. Lise, P. Piselli et al., Pattern of cancer risk in persons with AIDS in Italy in the HAART era, Cancer and AIDS Registries Linkage, vol.100, pp.840-847, 2009.

M. Michieli, M. Mazzucato, U. Tirelli, D. Paoli, and P. , Stem cell transplantation for lymphoma patients with HIV infection, Cell Transplant, vol.20, pp.351-370, 2011.

R. Ramaswami, A. D. Pria, K. Parker, S. Mccann, E. J. Kanfer et al., Outcomes of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory HIV-associated lymphoma, Bone Marrow Transplant, vol.51, pp.1609-1611, 2016.

J. C. Alvarnas, J. L. Rademacher, Y. Wang, R. F. Little, G. Akpek et al., Autologous hematopoietic cell transplantation for HIV, 2016.

, Trial. Blood, vol.128, pp.1050-1058

C. Simonelli, S. Zanussi, C. Pratesi, M. Rupolo, R. Talamini et al., Immune recovery after autologous stem cell transplantation is not different for HIV-infected versus HIV-uninfected patients with relapsed or refractory lymphoma, Clin. Infect. Dis, vol.50, pp.1672-1679, 2010.

D. L. Digiusto, A. Krishnan, L. Li, H. Li, S. Li et al., RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma, Sci. Transl. Med, vol.2, pp.36-43, 2010.

G. Hütter, D. Nowak, M. Mossner, S. Ganepola, A. Müssig et al., Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation, N. Engl. J. Med, vol.360, pp.692-698, 2009.

K. Allers, G. Hütter, J. Hofmann, C. Loddenkemper, K. Rieger et al., Evidence for the cure of HIV infection by CCR5D32/D32 stem cell transplantation, Blood, vol.117, pp.2791-2799, 2011.

K. Allers and T. Schneider, CCR5D32 mutation and HIV infection: basis for curative HIV therapy, Curr Opin Virol, vol.14, pp.24-29, 2015.

E. E. Perez, J. Wang, J. C. Miller, Y. Jouvenot, K. A. Kim et al., Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases, Nat. Biotechnol, vol.26, pp.808-816, 2008.

P. Tebas, D. Stein, W. W. Tang, I. Frank, S. Q. Wang et al., Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV, N. Engl. J. Med, vol.370, pp.901-910, 2014.

M. Egelhofer, G. Brandenburg, H. Martinius, P. Schult-dietrich, G. Melikyan et al., Inhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptides, J. Virol, vol.78, pp.568-575, 2004.

R. C. Zahn, F. G. Hermann, E. Kim, M. D. Rett, S. M. Wolinsky et al., Efficient entry inhibition of human and nonhuman primate immunodeficiency virus by cell surface-expressed gp41-derived peptides, Gene Ther, vol.15, pp.1210-1222, 2008.

J. Van-lunzen, T. Glaunsinger, I. Stahmer, V. Von-baehr, C. Baum et al., Transfer of autologous gene-modified T cells in HIV-infected patients with advanced immunodeficiency and drug-resistant virus, Mol. Ther, vol.15, pp.1024-1033, 2007.

O. Wolstein, M. Boyd, M. Millington, H. Impey, J. Boyer et al., Preclinical safety and efficacy of an anti-HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitor, Mol. Ther. Methods Clin. Dev, vol.1, p.11, 2014.

B. P. Burke, B. R. Levin, J. Zhang, A. Sahakyan, J. Boyer et al., Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral Vector, Mol. Ther. Nucleic Acids, vol.4, p.236, 2015.

S. Ledger, A. Howe, S. Turville, A. Aggarwal, B. Savkovic et al., Analysis and dissociation of anti-HIV effects of shRNA to CCR5 and the fusion inhibitor C46, J. Gene Med, vol.20, p.3006, 2018.